Card image cap

Jamie Raskin's Public Statements on Issue: Drugs

Office:

On The Ballot: Running, Democratic for U.S. House (MD) - District 8

Current Issue:

Drugs

Speech Type

All Debate Executive Order Floor Speech Hearing Interview Issue Position Letter News Article Op-Ed Other Pledge Press Conference Press Release Social Media Speech Statement

Date Range

Keyword Search
Reset Search
Page 1 of 2
Date Title
05/09/2023 New GAO Report Reveals Underreported Taxpayer Contributions to Pharma Research
12/07/2021 Letter to Hon. Chuck Schumer, Majority Leader US Senate - Keep Affordable Insulin Measures in Build Back Better Act
11/19/2021 RASKIN STATEMENT ON PASSAGE OF THE BUILD BACK BETTER ACT
11/16/2021 MARYLAND DELEGATION ANNOUNCES MORE THAN $1.6 MILLION FOR MARYLAND'S PRESCRIPTION DRUG MONITORING PROGRAM
08/02/2021 Cardin, Van Hollen, Raskin, Trone Announce Nearly $2 Million in American Rescue Plan Funding to Support Mental Health and Substance Use Treatment Services
12/18/2020 Bipartisan Outrage Towards Sackler Family and Purdue Pharma for Lack of Accountability in Role in Fueling Opioid Crisis
09/01/2020 Maryland Delegation Members Applaud $4.5 Million in Federal Funding to Combat Opioid Crisis
01/23/2020 Letter to Alex Azar, Secretary of the Department of Health and Human Services - Lawmakers Call on Administration to Ban Flavored Vaping Products
03/28/2019 Letter to Chairwoman Rosa DeLauro and Ranking Member Tom Cole - Congressman Rose Leads Push to Increase Funding for Opioid Treatment, Prevention Efforts
01/09/2019 Letter to the Hon. Nancy Pelosi, Speaker of the House, and the Hon. Steny Hoyer, House Majority Leader - Blunt Rochester Calls on House Leadership to Commit Additional Resources to Opioid & Addiction Treatment in the 116th Congress
01/09/2019 Letter to the Hon. Nancy Pelosi and the Hon. Steny Hoyer - Make Opioid Treatment a Top Priority Next Congress
06/15/2018 Stop the Importation and Trafficking of Synthetic Analogues Act of 2017
05/31/2018 Reps. Raskin, Mitchell, Rothfus Working to Track Opioid Crisis Efforts
03/16/2018 Letter to Chairman John Culberson and Ranking Member Jose Serrano, House Appropriations Subcommittee on Commerce, Justice, Science and Related Agencies - Add Marijuana Amendment to the FY2019 Budget
03/15/2018 Letter to Rodney Frelinghuysen, Chairman of the House Appropriations Committee and Nita Lowey, Ranking Member of the House Appropriations Committee - Bipartisan Heroin Task Force Urges Congress to Expand CARA Funding
03/09/2018 Letter to the Honorable Paul Ryan, Speaker of the House of Representatives, the Honorable Nancy Pelosi, House Democratic Leader, the Honorable Rodney Frelignhuysen, Chairman of House Appropriations Committee, and the Honorable Nite Lowey, Ranking Member of House Appropriations Committee - No Funding for DEA Cannabis Eradication Program
02/14/2018 Letter to the Hon. Bob Goodlatte, Chairman of the House Judiciary Committee - Judiciary Democrats Call For Real Hearings To Address Opioid Crisis
02/05/2018 Letter to the Honorable Bob Goodlatte, Chairman of House Judiciary Committee - Hearing on Marijuana Policy Change by Attorney General Sessions
01/25/2018 Letter to President Donald Trump - Senators Murray, Cantwell, Bipartisan Colleagues Urge President Trump to Keep Campaign Promise on State Marijuana Laws
01/19/2018 Letter to the Hon. Donald J. Trump, President of the United States - Declare Opioid Epidemic a National Emergency
11/28/2017 Letter to the Hon. Paul Ryan, Speaker of the House, the Hon. Nancy Pelosi, Democratic Leader of the House, the Hon. Mitch McConnell, Senate Majority Leader, and the Hon. Charles Schumer, Senate Minority Leader - Rep. Rohrabacher Leads Bipartisan Letter Urging Continuation of Policy Protecting State Medical Marijuana Laws
10/19/2017 Letter to Robert W. Patterson, DEA - Answers about DEA's Relationship with Pharma
08/22/2017 Letter to the Hon. Donald J. Trump, President - Implementation of Opioid Commission Recommendations
05/16/2017 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding
04/04/2017 Letter to the Hon. Donald Trump, President of the United States - Lower Prescription Drug Prices
Page 1 of 2
arrow_upward